Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

Hongyuan Chen,Ruizheng Miao,Junwei Fan,Zhongbo Han,Junyi Wu,Guoqiang Qiu,Huamei Tang,Zhihai Peng
DOI: https://doi.org/10.1007/s10585-013-9569-6
2013-01-01
Clinical & Experimental Metastasis
Abstract:The liver transplant (LT) situation represents an attractive model for studying hepatocellular carcinoma (HCC) metastasis. Based on microarray data, we previously found that miR-126 expression was lower in tumor tissues of patients with post-LT HCC recurrence compared with non-recurrence. In this study, we examined the expression of miR-126 in HCC samples from 68 patients who had undergone LT using quantitative real-time PCR and analyzed its correlation with clinicopathological features and prognosis of patients. Furthermore, we performed experimental analyses to explore the involvement of miR-126 in HCC metastasis. We found that miR-126 levels were lower in tumor tissues of patients with post-LT HCC recurrence in comparison to patients with no-recurrence ( p = 0.009). Lower expression of miR-126 in HCC was associated significantly with tumor recurrence ( p = 0.011) and poor survival ( p = 0.009) of patients. Functional studies indicated that ectopic expression of miR-126 significantly inhibits HCC cells migration, invasion, proliferation and colony formation in vitro, and suppresses experimental lung colonization in vivo. Our study revealed that down-regulation of miR-126 plays an important role in HCC metastasis, and suggest a potential application of miR-126 in prognosis prediction and HCC treatment.
What problem does this paper attempt to address?